Deal: India’s largest drug maker by market value Sun Pharmaceutical Industries Ltd is acquiring Mumbai-based Ranbaxy Laboratories Ltd, in an all-stock transaction, creating world’s fifth-largest generics drug maker and the country’s largest pharma company. The overall enterprise value of the deal is pegged at $4 billion while the equity value ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
